Merck Group Inaugurates State-of-the-Art Global Capability Centre in Bengaluru
Merck Group has officially inaugurated its new, cutting-edge Global Capability Centre (GCC) in Electronic City, Bengaluru. Spanning an impressive 17,000 square metres, the integrated...
New Hope for Thyroid Eye Disease Treatment as FDA Approves Lumvoa
Waltham-based Viridian Therapeutics (Nasdaq: VRDN) has secured U.S. Food and Drug Administration clearance for Lumvoa™ (veligrotug-vvze), marking the company's debut as a commercial-stage biotech and...
Not 100% Atta: FSSAI Slams ‘Eat Fit Digestive Biscuits’ for Deceptive Health Claims
The Food Safety and Standards Authority of India (FSSAI) has issued an official notice to SAJ Food Products following a consumer complaint regarding misleading labeling on...
GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00
GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...
Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...
